MedTrace Logo

Effect of DHEA on Skin Aging in Postmenopausal Women

NCT00248989 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-04-07

No results posted yet for this study

Summary

The purpose of the study is to determine the response of skin parameters related to skin aging to the local action of DHEA in postmenopausal women.

Conditions

  • Skin Aging
  • Quality of Life

Interventions

DRUG

Dehydroepiandrosterone

3.0 ml of 0.3% DHEA cream applied on the skin twice daily.

DRUG

Placebos

3.0 ml of placebo cream applied on the skin twice daily.

Sponsors & Collaborators

  • CHU de Quebec-Universite Laval

    lead OTHER

Principal Investigators

  • Leonello Cusan, MD, PhD · CHUL Research Center

  • Fernand Labrie, MD, PhD · CHUL Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-01
Primary Completion
2005-11-24
Completion
2008-11-13

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00248989 on ClinicalTrials.gov